EcoDrugPlus

Somatostatin Receptor 3

Ensembl ID : ENSPEMG00000029274
Gene Symbol: SSTR3
1 Cross references
249 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSPEMG00000013404
Gene Symbol: SSTR4
3 Cross references
100 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSPEMG00000003514
Gene Symbol: SSTR5
1 Cross references
256 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSPEMG00000019272
Gene Symbol: SPHK2
1 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSPEMG00000028825
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSPEMG00000020058
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSPEMG00000016883
Gene Symbol: LOC102915584
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSPEMG00000022591
Gene Symbol: SRD5A2
3 Cross references
263 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSPEMG00000019840
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSPEMG00000021707
Gene Symbol: SI
3 Cross references
200 Possible Orthologues:

Synuclein, Alpha

Ensembl ID : ENSPEMG00000019491
Gene Symbol: SNCA
1 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSPEMG00000023294
Gene Symbol: TACR1
3 Cross references
267 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).